Our privacy policy describes how Fidessa uses cookies on our website. If you continue using our website, you are consenting to our use of cookies. OK


There were a couple of interesting pieces in the FT last week that looked at how the levels of HFT activity may be on the wane, both here in Europe and in the US (High-frequency boom time hits slowdown, Super-fast traders feel heat from competition). Whilst HFT activity is notoriously hard to measure, the FT points to data collated by Tabb Group which seem to show a definite reversal in HFT volumes.

With this in mind, I thought it might be worth looking at how the LSE’s spangly new matching platform, Millennium Exchange, has fared in all this. As we know, a key objective of the Millennium Exchange project was to win back the HFT community, that had defected to the likes of Chi-X and BATS, by offering the same sort of low latency performance. Millennium Exchange was introduced at Turquoise on the 4th October last year and went live on LSE’s main market eventually in February 2011. The chart below seems to show that the effect has been somewhat mixed:

The question is whether this is because the HFT party is over or just that the HFT guys haven’t yet been convinced by the new platforms available within the LSE Group. It’s not all bad news for the LSE though, as some stocks do seem to have swung back their way as the chart for AstraZeneca below shows:

Anyway, have your say and we’ll publish the results next week.

[poll id=”9″]

P.S. Thanks to everyone for their enthusiastic reception of the Tradalyzer which we launched last week. Seems like the fragmentation community likes the idea of comparing its trades against our consolidated market view. If you haven’t seen it yet then just click here.

Leave a comment

Copyright © 2019 Fidessa Group Holdings Limited. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Fragulator® is a registered trademark of Fidessa Group Holdings Limited.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.